STOCK TITAN
  1. Home
  2. Sec-filings
  3. RADX
  4. [6-K] Radiopharm Theranostics Ltd Current Report (Foreign Issuer)

Theranostics Limited (RADX) reports expiry of 505,598 RADAN options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Theranostics Limited reported that 505,598 unquoted RADAN options expired on 31 May 2026 without being exercised or converted, meaning these potential shares will no longer be issued. No consideration was paid in connection with the cessation.

After this change, the company reports 3,544,216,160 RAD ordinary fully paid shares on issue, alongside multiple series of outstanding options, including 421,025,268 RADAN options and several other option classes with varying expiry dates and exercise prices.

Positive

  • None.

Negative

  • None.
RADAN options ceased 505,598 options Expired 31/05/2026 without exercise or conversion
Ordinary shares on issue 3,544,216,160 shares RAD ordinary fully paid shares on issue after cessation
RADAN options remaining 421,025,268 options RADAN options on issue following reported cessation
RADO options on issue 79,352,040 options RADO options expiring 30-Nov-2026
RADOA options on issue 818,890,534 options RADOA options expiring 24-Aug-2026
RADOB options on issue 1,179,266,658 options RADOB options expiring 31-Oct-2027
foreign private issuer regulatory
"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Form 6-K regulatory
"A copy of the Public Notice is attached as an exhibit to this report on Form 6-K."
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
expiry of option or other convertible security without exercise or conversion financial
"Expiry of option or other convertible security without exercise or conversion"
issued capital financial
"We (the entity named above) provide the following information about our issued capital."
+securities financial
"Details of +securities that have ceased"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 UNDER

THE SECURITIES EXCHANGE ACT OF 1934

 

For the Month of June 2026

 

Commission File Number: 001-41621

 

RADIOPHARM THERANOSTICS LIMITED

(Name of Registrant)

 

Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia

(Address of principal executive office)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒       Form 40-F ☐

 

 

 

 

 

RADIOPHARM THERANOSTICS LIMITED

 

EXPLANATORY NOTE

 

Radiopharm Theranostics Limited (the “Company”) published one announcement (the “Public Notice”) to the Australian Securities Exchange on June 3, 2026 titled:

 

“Notification of cessation of securities - RAD”

 

A copy of the Public Notice is attached as an exhibit to this report on Form 6-K.

 

This report on Form 6-K (including any exhibit hereto) shall not be deemed to be “filed” for purposes of the Securities Exchange Act of 1934 and shall not be incorporated by reference into any registration statement or prospectus under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such registration statement or prospectus.

 

1

 

 

EXHIBITS

 

Exhibit
Number		   Description
99.1   Notification of cessation of securities - RAD

 

2

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  RADIOPHARM THERANOSTICS LIMITED
     
Date: June 3, 2026 By: /s/ Nathan Jong
    Nathan Jong
    Company Secretary

 

3

 

Exhibit 99.1

 

  Appendix 3H - Notification of cessation of securities

 

Announcement Summary

 

 

 

Entity name

 

RADIOPHARM THERANOSTICS LIMITED

 

Announcement Type

 

New announcement

 

Date of this announcement

 

Wednesday June 03, 2026

 

Details of +securities that have ceased

 

ASX +security
code		   Security description   Number of
+securities that
have ceased		   The +securities have
ceased due to  		   Date of
cessation
RADAN   OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES   505,598   Expiry of option or other convertible security without exercise or conversion   31/05/2026

 

Refer to next page for full details of the announcement

 

Appendix 3H - Notification of cessation of securities1 / 4

 

 

  Appendix 3H - Notification of cessation of securities

 

Part 1 - Announcement Details

 

 

 

1.1Name of +Entity

 

RADIOPHARM THERANOSTICS LIMITED

 

We (the entity named above) provide the following information about our issued capital.

 

1.2Registered Number Type Registration Number
     
 ACN 647877889

 

1.3ASX issuer code

 

RAD

 

1.4The announcement is

 

New announcement

 

1.5Date of this announcement

 

3/6/2026

 

Appendix 3H - Notification of cessation of securities2 / 4

 

  Appendix 3H - Notification of cessation of securities

 

Part 2 - Details of +equity securities or +debt securities that have ceased

 

 

 

ASX +Security Code and Description

 

RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES

 

Unquoted +equity securities that have ceased

Number of securities that have ceased

 

505,598

 

Reason for cessation

 

Expiry of option or other convertible security without exercise or conversion

 

Date of cessation Is the entity paying any consideration for the cessation?
   
31/5/2026 No

 

Any other information the entity wishes to notify to ASX about the cessation?

 

   

 

Appendix 3H - Notification of cessation of securities3 / 4

 

  Appendix 3H - Notification of cessation of securities

 

Part 3 - Issued capital following changes

 

 

 

Following the cessation of the +securities the subject of this notification, the issued capital of the entity will comprise:

 

The figures in parts 3.1 and 3.2 below are automatically generated and may not reflect the entity's current issued capital if other Appendix 2A, Appendix 3G or Appendix 3H forms are currently with ASX for processing.

 

3.1Quoted +equity securities and +debt securities (total number of each +class of +securities quoted on ASX)

 

ASX +security code and description  Total
number of
+securities
on issue		 
     
RADO : OPTION EXPIRING 30-NOV-2026   79,352,040 
      
RAD : ORDINARY FULLY PAID   3,544,216,160 
      
RADOA : OPTION EXPIRING 24-AUG-2026   818,890,534 
      
RADOB : OPTION EXPIRING 31-OCT-2027   1,179,266,658 

 

3.2Unquoted +equity securities (total number of each +class of +equity securities issued but not quoted on ASX)

 

ASX +security code and description  Total
number of
+securities
on issue		 
     
RADAK : OPTION EXPIRING 01-JUN-2027 EX $0.60   1,666,500 
      
RADAN : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES   421,025,268 
      
RADAJ : OPTION EXPIRING 01-JUL-2027 EX $0.17   13,137,976 
      
RADAF : OPTION EXPIRING 25-NOV-2026 RESTRICTED   8,666,678 
      
RADAG : OPTION EXPIRING 25-NOV-2026 EX $0.60   5,066,672 
      
RADAI : OPTION EXPIRING 27-MAY-2027 EX $0.60   740,000 
      
RADAP : OPTION EXPIRING 24-APR-2028 EX $0.09   8,955,224 

 

Note: the figures stated in the tables above are used to calculate the total market capitalisation of the entity published by ASX from time to time. The table will not include those classes of +securities that have ceased or lapsed in their entirety in ASX records before the announcement date described in Q1.5, even if the entity has advised ASX of a change to that class of +security in Part 2 of this form.

 

Appendix 3H - Notification of cessation of securities4 / 4

 

Source: View Original Filing on SEC EDGAR

FAQ

What did Theranostics Limited (RADX) disclose in its June 2026 Form 6-K?

Theranostics Limited disclosed that 505,598 RADAN options expired on 31 May 2026 without exercise or conversion. This removes those potential shares from future issuance and slightly reduces the company’s outstanding option overhang.

How many Theranostics Limited RADAN options ceased in May 2026?

Theranostics Limited reported that 505,598 RADAN options ceased on 31 May 2026 due to expiry without exercise or conversion. These were unquoted equity securities and no consideration was paid for their cessation.

Did Theranostics Limited pay any consideration for the cessation of RADAN options?

No, Theranostics Limited confirmed it did not pay any consideration when 505,598 RADAN options ceased on 31 May 2026. The options simply expired unexercised, removing those rights to acquire shares.

What is Theranostics Limited’s ordinary share capital after the RADAN option expiry?

Following the reported option cessation, Theranostics Limited states it has 3,544,216,160 RAD ordinary fully paid shares on issue. This figure is used by ASX to help calculate the company’s market capitalisation from time to time.

How many RADAN options remain on issue for Theranostics Limited after the expiry?

After the expiry of some RADAN options, Theranostics Limited reports 421,025,268 RADAN options still on issue. These options have various expiry dates and exercise prices, separate from other option classes listed.

What other Theranostics Limited option classes are currently on issue?

Theranostics Limited lists several option classes on issue, including RADO, RADOA, RADOB, RADAK, RADAJ, RADAF, RADAG, RADAI and RADAP. Each class has its own total number of securities, expiry dates and, for some, specified exercise prices.

Filing Exhibits & Attachments

1 document

Press Releases